Crossmark Global Holdings, Inc. - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 4 filers reported holding ENCOMPASS HEALTH CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Crossmark Global Holdings, Inc. ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q3 2023$577
-7.1%
8,762
-6.8%
0.01%0.0%
Q2 2023$621
+21.1%
9,403
-0.9%
0.01%
+8.3%
Q1 2023$513
-10.2%
9,485
-0.6%
0.01%
-14.3%
Q4 2022$571
-99.9%
9,541
+1.0%
0.01%
+16.7%
Q3 2022$427,000
-93.6%
9,450
-92.0%
0.01%
-93.0%
Q2 2022$6,649,000
-20.9%
118,615
+0.4%
0.17%
-8.0%
Q1 2022$8,402,000
+1206.7%
118,147
+1098.2%
0.19%
+1235.7%
Q4 2021$643,000
-12.4%
9,860
+0.8%
0.01%
-17.6%
Q3 2021$734,000
-4.1%
9,781
-0.2%
0.02%
-5.6%
Q2 2021$765,000
-5.9%
9,801
-1.3%
0.02%
-10.0%
Q1 2021$813,000
-92.4%
9,928
-92.3%
0.02%
-92.6%
Q4 2020$10,691,000
+19.1%
129,290
-6.4%
0.27%
+7.1%
Q3 2020$8,978,000
+2.2%
138,169
-2.6%
0.25%
-1.6%
Q2 2020$8,784,000
-6.6%
141,836
-3.4%
0.26%
-23.8%
Q1 2020$9,403,000
-17.0%
146,858
-10.2%
0.34%
+8.0%
Q4 2019$11,325,000
+10.1%
163,496
+0.6%
0.31%
+3.7%
Q3 2019$10,287,000
-1.6%
162,568
-1.5%
0.30%
+2.4%
Q2 2019$10,456,000
+8.6%
165,033
+0.1%
0.29%
+7.3%
Q1 2019$9,631,000
-6.4%
164,915
-1.1%
0.27%
-14.4%
Q4 2018$10,287,000
-21.5%
166,722
-0.8%
0.32%
-4.2%
Q3 2018$13,104,000
+19.3%
168,106
+3.6%
0.33%
+12.9%
Q2 2018$10,986,000
+25.0%
162,223
+5.5%
0.30%
+30.0%
Q1 2018$8,788,000153,7140.23%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Copeland Capital Management, LLC 569,048$28,117,0001.78%
Kalos Management, Inc. 76,118$3,761,0001.77%
Bridge City Capital, LLC 30,231$1,494,0001.08%
DALTON GREINER HARTMAN MAHER & CO 331,823$16,395,0000.86%
Horrell Capital Management, Inc. 28,641$1,415,0000.74%
Polianta Ltd 26,600$1,314,0000.43%
GLOBEFLEX CAPITAL L P 30,177$1,491,0000.42%
CARILLON TOWER ADVISERS, INC. 768,748$37,984,0000.40%
EAGLE ASSET MANAGEMENT INC 1,070,271$53,001,0000.29%
S. R. Schill & Associates 8,108$401,0000.25%
View complete list of ENCOMPASS HEALTH CORP shareholders